Cover Image

Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase

The inhibition of liver pyruvate kinase could be beneficial to halt or reverse non-alcoholic fatty liver disease (NAFLD), a progressive accumulation of fat in the liver that can lead eventually to cirrhosis. Recently, urolithin C has been reported as a new scaffold for the development of allosteric...

Full description

Saved in:
Bibliographic Details
Main Authors: Umberto Maria Battisti (Author), Leticia Monjas (Author), Fady Akladios (Author), Josipa Matic (Author), Eric Andresen (Author), Carolin H. Nagel (Author), Malin Hagkvist (Author), Liliana Håversen (Author), Woonghee Kim (Author), Mathias Uhlen (Author), Jan Borén (Author), Adil Mardinoğlu (Author), Morten Grøtli (Author)
Format: Book
Published: MDPI AG, 2023-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The inhibition of liver pyruvate kinase could be beneficial to halt or reverse non-alcoholic fatty liver disease (NAFLD), a progressive accumulation of fat in the liver that can lead eventually to cirrhosis. Recently, urolithin C has been reported as a new scaffold for the development of allosteric inhibitors of liver pyruvate kinase (PKL). In this work, a comprehensive structure-activity analysis of urolithin C was carried out. More than 50 analogues were synthesized and tested regarding the chemical features responsible for the desired activity. These data could pave the way to the development of more potent and selective PKL allosteric inhibitors.
Item Description:10.3390/ph16050668
1424-8247

Similar Items